1411 |
Landscape of Lipid Management Following an ACS Event |
Choongki Kim |
Apr. 08. 22 |
1410 |
How is SAPIEN 3 Valve Design Connected to Clinical Benefit? |
Young-Guk Ko |
Apr. 08. 22 |
1409 |
Strategies of IVUS-Guided Left Main PCI with SYNERGY MEGATRON¢â BP Stent |
Jeehoon Kang |
Apr. 08. 22 |
1408 |
SYNERGY MEGATRON – Advancing Your Large Proximal Vessel Strategy for Improved Outcomes |
Huay Cheem Tan |
Apr. 08. 22 |
1407 |
Comparison of 2 Different Paclitaxel-coated Balloons in Coronary In-stent Restenosis: A Randomized Controlled Trial |
Eun-Seok Shin |
Apr. 08. 22 |
1406 |
Influence of Baseline HbA1c and Antiplatelet Therapy on 1-year Vein Graft Outcome |
Qiang Zhao |
Apr. 08. 22 |
1405 |
Sex Differences in Plaque Characteristics and Myocardial Mass: Implications for Physiologic Significance |
Bon-Kwon Koo |
Apr. 08. 22 |
1404 |
Case IV: STEMI and Intracranial Hemorrhage: Double Trouble |
Amir Aziz Alkatiri |
Apr. 08. 22 |
1403 |
Case III: Stent or No Stent Dilemma in PPCI |
Tito Phurbojoyo |
Apr. 08. 22 |
1402 |
Case II: Gastro Intestinal Bleeding After Left Main Stenting in Primary PCI |
Andi Haryanto |
Apr. 08. 22 |